NPM1 and acute myeloid leukemia: The only important difference compared to the ICC 2022 is that in the WHO 2022 classification, no blast enumeration threshold exists as a prerequisite for diagnosis, as AML with NPM1 mutation is diagnosed irrespective of the blast count [32,33,34].